Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-2-9
pubmed:abstractText
Toll-like receptor (TLR) ligands are notable for their ability to induce APC maturation, which in turn facilitates optimal T cell mediated immune responses. Toll-like receptor ligands, such as CpG DNA, can also modulate immune responses by blocking the suppressive effects of CD4+CD25+ regulatory T cells (Tregs). Recently, we have demonstrated that CpG DNA, in addition to its actions on APCs and Tregs, can provide direct costimulatory signals to CD4+CD25- T cells. Here we show that this costimulatory effect is sufficient to abrogate suppression by Tregs. These data indicate a previously undefined role for TLR ligands in directly modulating CD4+ T cell responses.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-11130078, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-11286707, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-11477402, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-12532024, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-12626561, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-14981245, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-15128790, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-15153463, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-15678105, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-15785760, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-16123302, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-16339542, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-16632602, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-16868552, http://linkedlifedata.com/resource/pubmed/commentcorrection/17270282-9670041
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0165-2478
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
183-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:17270282-Adjuvants, Immunologic, pubmed-meshheading:17270282-Animals, pubmed-meshheading:17270282-Antigen-Presenting Cells, pubmed-meshheading:17270282-CD4-Positive T-Lymphocytes, pubmed-meshheading:17270282-Cell Proliferation, pubmed-meshheading:17270282-Coculture Techniques, pubmed-meshheading:17270282-Forkhead Transcription Factors, pubmed-meshheading:17270282-Immune Tolerance, pubmed-meshheading:17270282-Interleukin-2, pubmed-meshheading:17270282-Interleukin-2 Receptor alpha Subunit, pubmed-meshheading:17270282-Lymphocyte Activation, pubmed-meshheading:17270282-Mice, pubmed-meshheading:17270282-Mice, Inbred C57BL, pubmed-meshheading:17270282-Mice, Knockout, pubmed-meshheading:17270282-Myeloid Differentiation Factor 88, pubmed-meshheading:17270282-Oligodeoxyribonucleotides, pubmed-meshheading:17270282-T-Lymphocytes, Regulatory
pubmed:year
2007
pubmed:articleTitle
CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.
pubmed:affiliation
Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural